Nontrfuil, France

Annie Michaud

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annie Michaud. Retrieved from https://idiyas.com/inventor/annie-michaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Annie Michaud

Introduction

Annie Michaud is a notable inventor based in Nontrufuil, France. He has made significant contributions to the field of medical science, particularly in the development of inhibitors for human angiotensin conversion enzyme (ACE). His work has the potential to impact treatments for various cardiovascular conditions.

Latest Patents

Annie Michaud holds 1 patent for his invention titled "N-terminal site selective inhibitors of human angiotensin conversion enzyme (ACE)." This patent represents a crucial advancement in the search for effective therapies targeting ACE, which plays a vital role in regulating blood pressure.

Career Highlights

Throughout his career, Annie Michaud has focused on innovative solutions in the medical field. His dedication to research and development has led to breakthroughs that enhance our understanding of cardiovascular health. His work exemplifies the intersection of science and practical application.

Collaborations

Annie Michaud has collaborated with esteemed colleagues, including Vincent Dive and Joël Cotton. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing their collective research efforts.

Conclusion

Annie Michaud's contributions to the field of medical science through his patent and collaborations highlight the importance of innovation in healthcare. His work continues to inspire future advancements in the treatment of cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…